MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 208 filers reported holding MIRATI THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 1.52 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $203,895 | -35.1% | 4,500 | 0.0% | 0.03% | -38.9% |
| Q3 2022 | $314,000 | +4.0% | 4,500 | 0.0% | 0.05% | +10.2% |
| Q2 2022 | $302,000 | -18.4% | 4,500 | 0.0% | 0.05% | -2.0% |
| Q1 2022 | $370,000 | -43.9% | 4,500 | 0.0% | 0.05% | -39.8% |
| Q4 2021 | $660,000 | -17.1% | 4,500 | 0.0% | 0.08% | -23.1% |
| Q3 2021 | $796,000 | +9.5% | 4,500 | 0.0% | 0.11% | +11.3% |
| Q2 2021 | $727,000 | -5.7% | 4,500 | 0.0% | 0.10% | -11.8% |
| Q1 2021 | $771,000 | -22.0% | 4,500 | 0.0% | 0.11% | -27.6% |
| Q4 2020 | $988,000 | +32.3% | 4,500 | 0.0% | 0.15% | +13.4% |
| Q3 2020 | $747,000 | +45.3% | 4,500 | 0.0% | 0.13% | +38.1% |
| Q2 2020 | $514,000 | +48.6% | 4,500 | 0.0% | 0.10% | +22.8% |
| Q1 2020 | $346,000 | -40.3% | 4,500 | 0.0% | 0.08% | -19.4% |
| Q4 2019 | $580,000 | – | 4,500 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |